title: Use of cefepime for the treatment of infections caused by extended spectrum: beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
authors.forename: Subhash C
authors.initials: SC
authors.lastname: Arya
authors.forename: Nirmala
authors.initials: N
authors.lastname: Agarwal
authors.forename: Bhavani S
authors.initials: BS
authors.lastname: Solanki
authors.forename: Shekhar
authors.initials: S
authors.lastname: Agarwal
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000077723:Cefepime; D002511:Cephalosporins / Q000627:therapeutic use*; D024901:Drug Resistance, Multiple, Bacterial; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy*; D006786:Hospitals, Urban; D006801:Humans; D007194:India; D007362:Intensive Care Units; D007710:Klebsiella Infections / Q000188:drug therapy*; D007711:Klebsiella pneumoniae / Q000187:drug effects; D000077731:Meropenem; D008826:Microbial Sensitivity Tests; D010397:Penicillanic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D010878:Piperacillin / Q000627:therapeutic use; D000077725:Piperacillin, Tazobactam Drug Combination; D018805:Sepsis / Q000188:drug therapy; D013845:Thienamycins / Q000627:therapeutic use; D001618:beta-Lactamases / Q000032:analysis / Q000187:drug effects*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D013845:Thienamycins; D000077725:Piperacillin, Tazobactam Drug Combination; D000077723:Cefepime; D010397:Penicillanic Acid; D001618:beta-Lactamases; D000077731:Meropenem; D010878:Piperacillin